Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

GE HealthCare (Nasdaq: GEHC) today announced a $138 million investment to expand its Carrigtohill, Cork contrast media fill ...

Kirin Holdings Company, Limited (Kirin Holdings) (TOKYO:2503) and Mitsui Norin Co., Ltd. (Mitsui Norin) are developing a ...

Israel to free 90 prisoners in Saturday hostage swap: Palestinian NGO Reply has announced the opening of registrations for ...

Estée Lauder today announces that actor, writer, model and anti-ageism activist Paulina Porizkova, will return to the brand ...

Americhem, Inc., a globally recognized designer and manufacturer of custom color masterbatch, functional additives, ...

SPIE, the international society for optics and photonics, recognized the top-rated new optics and photonics products with the ...

LTIM, BSE: 540005], a global technology consulting and digital solutions company, has partnered with FLS, a leading, full ...

Galderma (SWX:GALD), the pure-play dermatology category leader, announced today results from its new phase IIIb RELAX clinical trial demonstrating the rapid onset and the long-lasting duration of ...

Adtran today launched its Enhanced Short-Term Unit (ESTU) precision timing module, a new addition to its OSA 3300 ...

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...

Storm Reply, a specialist in professional cloud computing services, has been selected by GROHE, the global leader in sanitary ...